HISTORY

2019

February

  • Entering into MOU to develop RMAT (Regenerative Medicine Advanced Treatment) programs in collaborations with Seoul National University Bundang Hospital

January

  • Signed a contract with governor of Chungcheongbuk-do to move into the
    Advanced Medical Complex in Oh-song

2018

October

  • Entering into MOU to develop RMAT (Regenerative Medicine Advanced Treatment) programs in collaborations with Ewha Woman’s University Medical Center

September

  • Entering into Exclusive License Agreements with Ewha Woman’s University on patents relating to methods of differentiating neuro-muscular tissue cells from Tonsil-mesenchymal stem cells (T-MSC) for the worldwide territory.

July

  • Entering into Technology & Patent Transfer Agreement with Chonbuk National University on a research program related to Musculoskeletal Stem Cells (MSSC)
  • Becoming a regular member of CARM (Council for Advanced Regenerative Medicine)

June

  • Inviting seed investment from Venture Capitals (KRW 15B)

February

  • Opening head office & research laboratory within Institut Pasteur Korea
  • Designated as a Venture Company accredited by KIBO (Korea Technology Finance Corporation)

January

  • Obtaining a certification of Company-owned Research Laboratory from KOITA (Korea Industrial Technology Association)

2017

November

  • Cellatoz Therapeutics, Inc. was selected as one of five incubating startup biotechs in BIO Core Facility Program operated by Institut Pasteur Korea and funded by MSIT (Ministry of Science and ICT)

August

  • Establishing Cellatoz Therapeutics, Inc.